Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Autonomic Technologies Taps Thoratec Alumni For Leadership Roles

This article was originally published in Clinica

Executive Summary

Autonomic Technologies Inc., the developer of the CE-marked Pulsante microstimulator to treat cluster headaches, has appointed Niamh Pellegrini president and CEO and Gerhard Burbach chairman. Both Pellegrini and Burbach was previously with Thoratec, the specialist in implantable heart assist devices; Thoratec was acquired by St Jude Medical in 2015. Pellegrini was formerly president, North America, at Thoratec. She replaces Ben Pless, who stepped down from in December 2015 and is now an industry consultant. Burbach was the former CEO of Thoratec. The appointments come as Redwood, California-based ATI seeks to expand EU commercialization of Pulsante, which stimulates the sphenopalatine ganglion, and speed up its US clinical trial. The company set up its European headquarters in Germany last year.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst